On March 2, 2021 Kintara Therapeutics, Inc. (NASDAQ: KTRA) ("Kintara" or the "Company"), a biopharmaceutical company focused on the development of new solid tumor cancer therapies, reported that its President and CEO Saiid Zarrabian will present at the H.C. Wainwright Global Life Sciences Conference taking place March 9-10, 2021 (Press release, Kintara Therapeutics, MAR 2, 2021, View Source [SID1234575960]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

The presentation will be available on-demand beginning at 7:00 A.M. ET on Tuesday, March 9, 2021 and will be available for 90 days. For those interested in viewing Mr. Zarrabian’s presentation, conference registration can be accessed here. Mr. Zarrabian will also be available for virtual one-on-one meetings on March 9-10, 2021 and meeting requests can be made once registered.